Is 7-OH Legal in Idaho? The Pending 2026 Federal Ban, Explained

Short version: as of October 14, 2026, 7-OH is still legal in Idaho. The state hasn’t restricted it, and the federal ban on concentrated 7-OH hasn’t taken effect. Under the DEA’s newest notice, it can’t take effect before November 13, 2026. For now, it’s legal to buy and sell, except in a few cities and counties that ban kratom sales; Coeur d’Alene caps 7-OH and requires buyers to be 21.

The “for now” is doing real work. The DEA filed in July to put concentrated 7-OH in Schedule I, then on October 14, 2026 withdrew that notice and filed a new one with a different line, one that also covers a related substance, mitragynine pseudoindoxyl. When the order lands, it changes the answer for the concentrated, isolated products, the tablets and shots. Natural leaf with only trace 7-OH is what the DEA says its threshold is built to leave out, though the notice doesn’t exempt leaf by name. Those two get lumped under one name, and that mix-up is the whole reason people are searching whether Idaho is banning kratom.

What 7-OH is, and how it differs from kratom

7-hydroxymitragynine, shortened to 7-OH, is one of the alkaloids in the kratom plant, Mitragyna speciosa. In raw leaf it’s a minor one. The DEA’s October filing puts it at under two percent of the total alkaloid content, often just a trace. Mitragynine is the major alkaloid in the plant; 7-OH is the small one riding along with it.

The product that set off the 2026 crackdown isn’t the leaf. It’s isolated 7-OH, concentrated far past what the plant makes and pressed into tablets, gummies, shots, and dissolvable strips. Same molecule, very different amount. That gap is the entire story, because the law is being written around a concentration line, not around the plant.

Is 7-OH legal in Idaho right now?

Yes, and it isn’t close at the state level. Idaho’s controlled substances schedules, in Idaho Code 37-2705, don’t list kratom, mitragynine, or 7-hydroxymitragynine. If a substance isn’t on the schedule, it isn’t controlled in Idaho, and none of these are. The state took two runs at changing kratom law in 2026, one bill to ban it and one to regulate it, and both failed, which our companion guide on kratom’s Idaho status walks through. So Idaho itself has not banned 7-OH or set a purchase age for it.

Local rules are another matter. Kellogg, Idaho Falls, Blackfoot, Shelley, and Bonneville and Bingham counties ban kratom sales, and 7-OH is a kratom alkaloid, so don’t count on buying it there. Coeur d’Alene’s September 15, 2026 ordinance requires a city license, bars sales to anyone under 21, and caps 7-OH at 2% of total alkaloids and 1 milligram per serving. Our kratom guide keeps the full list of local rules with sources.

Beyond those local rules, the pressure on 7-OH is federal, and as of this writing that federal ban hasn’t taken effect. So the straight answer today is that 7-OH is legal to buy and sell in most of Idaho. The other caveat is timing: the concentrated form is still on a federal clock, and the next two sections lay out where that clock actually stands after October 14.

What the DEA actually did in 2026

On July 6, 2026, the DEA published a notice of intent to place 7-OH above a set threshold into Schedule I of the Controlled Substances Act, the most restrictive tier under federal drug law. A notice of intent is the required first step, not the ban itself. That July notice never became an order. HHS took public comment on its threshold through September 10, 2026, and on October 8 sent the DEA a letter recommending a new one.

On October 14, 2026, the DEA published a new notice of intent (document 2026-20943, 91 FR 65370) built on that letter. It covers 7-OH and mitragynine pseudoindoxyl together, and it says of the July notice: “DEA is withdrawing that notice of intent elsewhere in this issue of the Federal Register.” The new notice says the temporary order “will be published in the Federal Register on or after November 13, 2026.” It takes effect the day it publishes and stays in place for “two years, with a possible extension of an additional year.”

As of October 14, 2026, that order hadn’t published. The notice is on the books; the scheduling order is not.

One line in the filing is the one to hold onto: the DEA says it chose a threshold over a blanket listing because 7-OH and mitragynine pseudoindoxyl “have supposedly been found in trace amounts in some botanical kratom products.”

What changed on August 26, 2026

One piece of the 7-OH story did move on August 26, and it’s easy to misread. The DEA issued a temporary order placing three substances the agency calls “7-hydroxymitragynine-related” into Schedule I: mitragynine pseudoindoxyl, MGM-15, and MGM-16, along with their isomers, esters, ethers, and salts. It’s effective August 26, 2026 through August 26, 2028, on a finding that scheduling them was necessary to avoid an imminent hazard to public safety.

Read the names carefully, because this is the part that gets reported as “the 7-OH ban.” It isn’t. Those three are relatives of 7-OH, not 7-OH itself, and not leaf kratom. The August 26 order is also about to change shape. In its October 14 notice the DEA says it “intends to withdraw the temporary order placing mitragynine pseudoindoxyl and replace it with a new temporary order,” the threshold order that covers 7-OH too. Until that happens, the August 26 order “remains in effect until either it expires or the new temporary order is published and the previous order is withdrawn, whichever occurs first,” so mitragynine pseudoindoxyl is Schedule I today with no threshold at all.

MGM-15 and MGM-16 got their own October 14 notice of intent (document 2026-20942), a procedural step that keeps both in Schedule I “without change.” So if you’re tracking what’s legal to buy: the August 26 order controls products built on mitragynine pseudoindoxyl, MGM-15, or MGM-16, while concentrated 7-OH is still legal at the federal level until the new order publishes.

The threshold, in plain terms

The 7-OH ban is a concentration line, not a blanket. Under the October notice, a product is Schedule I when 7-OH alone, mitragynine pseudoindoxyl alone, or the two combined fail either of two tests:

• More than 1 milligram per gram for solid powders, capsules, and other solid forms, or more than 1 milligram per milliliter for liquids.
• The mass of mitragynine divided by the mass of 7-OH (or of mitragynine pseudoindoxyl, or both combined) is less than 100. Put plainly, the product has less than 100 times as much mitragynine as 7-OH.

Failing either one is enough. That replaces the July notice’s line, which was written as a percentage of weight.

Hold that against the shelf. A concentrated 7-OH tablet or shot is built to go far over the 1 mg per gram line, because that concentration is the point of the product, so it fails the first test. The second test catches anything where 7-OH has been pushed up relative to mitragynine. In leaf, mitragynine is the major alkaloid and 7-OH a minor one, and trace amounts in some botanical kratom are the DEA’s stated reason for drawing a line at all. The notice doesn’t say every leaf product passes both tests, so we don’t promise that either.

The DEA is also clear about what the line doesn’t mean: “neither HHS nor DEA has made a finding that these substances are safe to use at below-threshold levels.” That’s the agencies’ statement about their own rule, not a claim we’re making about anyone’s health.

Where the FDA fits

The FDA got there first. In July 2025 it recommended that the DEA schedule concentrated 7-OH, and it was explicit that it was “specifically targeting 7-OH, a concentrated byproduct of the kratom plant,” not natural kratom leaf. The agency classifies 7-OH as an opioid, had already sent warning letters to seven companies selling 7-OH tablets, gummies, and shots, and has since seized products and stated the products aren’t approved for any use and can’t lawfully go in dietary supplements or foods.

That’s the federal government’s stated basis for the action, not a claim we’re making about anyone’s health. It’s also why the concentrated corner of this market is the risky place to be standing.

What this means if you buy kratom in Cache Valley

If you buy plain leaf kratom, nothing has changed today. Leaf kratom is legal in Idaho, no federal order targets it, and it stays on the shelf. We carry leaf-based kratom, and we still stock 7-OH too, because it is legal to sell in Idaho today. The August 26 order didn’t touch it; that order controlled three related substances, not 7-OH itself. We keep 7-OH on the shelf right up until its own federal ban takes effect; the day that Schedule I order publishes, the concentrated 7-OH products come off, and leaf stays as long as it sits under the new line.

Coming from the Utah side, the rules on kratom are tighter to begin with, pure leaf only and buyers 21 and older, and Utah now lists 7-OH itself as a Schedule I drug outside of pure leaf, which our Utah kratom guide covers. Either way, for kratom in Logan or anywhere else in the valley, here is the honest read: leaf kratom is on far steadier ground, since trace natural 7-OH is what the DEA says its threshold is built around, while concentrated 7-OH is legal to buy here in Idaho for now but still on a federal clock, one that can’t run out before November 13, 2026, so it is the piece that goes away when the 7-OH order lands. We stock both today and card every kratom customer at 21 and older, the same as pouches and vapes.

Sources and methodology

Every legal claim here was verified against a primary source on September 2, 2026, and the federal 7-OH sections were rechecked on October 14, 2026 against the Federal Register’s JSON API and its full-text copy of that day’s notices: the DEA has filed a new notice of intent, and no order on concentrated 7-OH has published. A Federal Register API search on October 15, 2026 still listed no such order. Federal Register and FDA pages block automated fetching, so each was read from the Federal Register’s own JSON API and full-text files and, where needed, rendered in a browser and quoted from the rendered text.

• DEA 7-OH action: the October 14, 2026 notice of intent (document 2026-20943, 91 FR 65370, Docket DEA-1570) to place 7-hydroxymitragynine and mitragynine pseudoindoxyl above a specified threshold in Schedule I, including the threshold, the “on or after November 13, 2026” publication language, the two-year term, the withdrawal of the July notice, the plan to replace the August 26 order for mitragynine pseudoindoxyl, and the HHS letter of October 8, 2026 it rests on. As of October 14, 2026 no 7-OH scheduling order had published, and the separate withdrawal notice for the July filing was not yet listed in the Federal Register API.
• MGM-15 and MGM-16: the DEA’s October 14, 2026 notice of intent (document 2026-20942, 91 FR 65381) to keep both in Schedule I without change.
• July notice, now withdrawn: the DEA’s July 6, 2026 notice of intent (91 FR 40917), which the October notice withdraws, and the HHS extension of the comment period (document 2026-17409) that kept comment on its threshold open to September 10, 2026.
• August 26 three-substance order: DEA temporary order Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (document 2026-17429, published August 26, 2026), placing those three 7-OH-related substances in Schedule I effective August 26, 2026 through August 26, 2028, on an imminent-hazard finding. It does not cover 7-OH itself.
• Natural leaf: the October DEA notice describes 7-OH as under two percent of the total alkaloid content in natural leaf and ties the threshold to trace amounts found in some botanical kratom products. It has no sentence exempting leaf by name.
• FDA: the July 2025 recommendation to schedule concentrated 7-OH, and the FDA’s 7-OH resource page.
• Idaho: Idaho Code 37-2705, where kratom and its alkaloids are absent from the schedules. Idaho’s 2026 bills, Utah’s rules, and the local sales bans and Coeur d’Alene ordinance are carried from our companion guide, Is Kratom Legal in Idaho?, which cites each city and county source; Kellogg, Blackfoot, and Bingham County rest on regional news reports.

The 7-OH order can’t publish before November 13, 2026 but has no set date after that, so if you’re making a decision that turns on 7-OH’s status, check the current Federal Register listing or confirm with the retailer.